mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.004 |
0.9 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.004 |
0.9 |
mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
0.0036 |
0.9 |
mRNA |
PF-3758309 |
CTRPv2 |
pan-cancer |
AAC |
0.0046 |
0.9 |
mRNA |
BIRB 0796 |
CTRPv2 |
pan-cancer |
AAC |
-0.004 |
0.9 |
mRNA |
Tamoxifen |
CTRPv2 |
pan-cancer |
AAC |
-0.004 |
0.9 |
mRNA |
OSI-930 |
CTRPv2 |
pan-cancer |
AAC |
-0.0038 |
0.9 |
mRNA |
BRD-K33199242 |
CTRPv2 |
pan-cancer |
AAC |
0.0038 |
0.9 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
0.0031 |
0.9 |
mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.0031 |
0.9 |